Orthopediatrics Depreciation & Amortization Growth & History (KIDS)
Orthopediatrics's depreciation and amortization was $21.1M for fiscal 2025.
View full Orthopediatrics company overviewOrthopediatrics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $21.1M | $2.0M | +10.69% |
| 2024 | 2024-12-31 | $19.1M | $1.7M | +9.75% |
| 2023 | 2023-12-31 | $17.4M | $4.3M | +32.72% |
| 2022 | 2022-12-31 | $13.1M | $2.4M | +22.65% |
| 2021 | 2021-12-31 | $10.7M | $2.7M | +33.33% |
| 2020 | 2020-12-31 | $8.0M | $3.3M | +71.48% |
| 2019 | 2019-12-31 | $4.7M | $1.8M | +61.51% |
| 2018 | 2018-12-31 | $2.9M | $487,000 | +20.25% |
| 2017 | 2017-12-31 | $2.4M | $503,000 | +26.45% |
| 2016 | 2016-12-31 | $1.9M | $48,000 | +2.59% |
| 2015 | 2015-12-31 | $1.9M | — | — |
Orthopediatrics quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.7M | $536,000 | +10.37% |
| Q1 2026 | 2026-03-31 | $5.7M | $673,000 | +13.33% |
| Q4 2025 | 2025-12-31 | $5.6M | — | — |
| Q3 2025 | 2025-09-30 | $5.3M | $19,000 | +0.36% |
| Q2 2025 | 2025-06-30 | $5.2M | $391,000 | +8.18% |
| Q1 2025 | 2025-03-31 | $5.0M | $20,000 | +0.40% |
| Q3 2024 | 2024-09-30 | $5.3M | $1.0M | +23.65% |
| Q2 2024 | 2024-06-30 | $4.8M | $699,000 | +17.13% |
| Q1 2024 | 2024-03-31 | $5.0M | $1.2M | +30.67% |
| Q3 2023 | 2023-09-30 | $4.3M | $983,000 | +29.91% |
| Q2 2023 | 2023-06-30 | $4.1M | $749,000 | +22.49% |
| Q1 2023 | 2023-03-31 | $3.8M | $887,000 | +29.96% |
| Q3 2022 | 2022-09-30 | $3.3M | $564,000 | +20.71% |
| Q2 2022 | 2022-06-30 | $3.3M | $723,000 | +27.72% |
| Q1 2022 | 2022-03-31 | $3.0M | $422,000 | +16.62% |
| Q3 2021 | 2021-09-30 | $2.7M | $312,000 | +12.94% |
| Q2 2021 | 2021-06-30 | $2.6M | $698,000 | +36.54% |
| Q1 2021 | 2021-03-31 | $2.5M | $1.2M | +84.65% |
| Q3 2020 | 2020-09-30 | $2.4M | $1.1M | +79.12% |
| Q2 2020 | 2020-06-30 | $1.9M | $826,000 | +76.20% |
| Q1 2020 | 2020-03-31 | $1.4M | $547,000 | +66.06% |
| Q3 2019 | 2019-09-30 | $1.3M | $569,000 | +73.23% |
| Q2 2019 | 2019-06-30 | $1.1M | $365,000 | +50.76% |
| Q1 2019 | 2019-03-31 | $828,000 | $147,000 | +21.59% |
| Q3 2018 | 2018-09-30 | $777,000 | $121,000 | +18.45% |
| Q2 2018 | 2018-06-30 | $719,000 | $125,000 | +21.04% |
| Q1 2018 | 2018-03-31 | $681,000 | $183,000 | +36.75% |
| Q3 2017 | 2017-09-30 | $656,000 | — | — |
| Q2 2017 | 2017-06-30 | $594,000 | — | — |
| Q1 2017 | 2017-03-31 | $498,000 | — | — |
Orthopediatrics depreciation and amortization trends
Over the last five fiscal years, Orthopediatrics's depreciation and amortization increased from $8.0M to $21.1M, a change of $13.1M. The latest reported quarter, Q2 2026, shows $5.7M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orthopediatrics source filings ↗